BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33536423)

  • 21. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The brachyury Gly177Asp SNP is not associated with a risk of skull base chordoma in the Chinese population.
    Wu Z; Wang K; Wang L; Feng J; Hao S; Tian K; Zhang L; Jia G; Wan H; Zhang J
    Int J Mol Sci; 2013 Oct; 14(11):21258-65. PubMed ID: 24232574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
    Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
    J Neurosurg; 2020 Jun; 134(5):1399-1408. PubMed ID: 32559743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological implications of TIM3
    Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
    Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes.
    Bai J; Shi J; Zhang Y; Li C; Xiong Y; Koka H; Wang D; Zhang T; Song L; Luo W; Zhu B; Hicks B; Hutchinson A; Kirk E; Troester MA; Li M; Shen Y; Ma T; Wang J; Liu X; Wang S; Gui S; McMaster ML; Chanock SJ; Parry DM; Goldstein AM; Yang XR
    Clin Cancer Res; 2023 Jan; 29(1):261-270. PubMed ID: 36260525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cytogenetic abnormalities on the management of skull base chordomas.
    Almefty KK; Pravdenkova S; Sawyer J; Al-Mefty O
    J Neurosurg; 2009 Apr; 110(4):715-24. PubMed ID: 19133754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities.
    Jahangiri A; Chin AT; Wagner JR; Kunwar S; Ames C; Chou D; Barani I; Parsa AT; McDermott MW; Benet A; El-Sayed IH; Aghi MK
    Neurosurgery; 2015 Feb; 76(2):179-85; discussion 185-6. PubMed ID: 25594191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular aspects of chordoma.
    Gulluoglu S; Turksoy O; Kuskucu A; Ture U; Bayrak OF
    Neurosurg Rev; 2016 Apr; 39(2):185-96; discussion 196. PubMed ID: 26363792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
    Gill CM; Fowkes M; Shrivastava RK
    Neurosurgery; 2020 Feb; 86(2):E118-E123. PubMed ID: 31504814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T gene isoform expression pattern is significantly different between chordomas and notochords.
    Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
    Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma.
    Zhu GG; Ramirez D; Chen W; Lu C; Wang L; Frosina D; Jungbluth A; Ntiamoah P; Nafa K; Boland PJ; Hameed MR
    Hum Pathol; 2020 Oct; 104():73-83. PubMed ID: 32795465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative Analysis.
    Hung YP; Diaz-Perez JA; Cote GM; Wejde J; Schwab JH; Nardi V; Chebib IA; Deshpande V; Selig MK; Bredella MA; Rosenberg AE; Nielsen GP
    Am J Surg Pathol; 2020 Sep; 44(9):1213-1223. PubMed ID: 32427623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?
    Sawyer JR; Husain M; Al-Mefty O
    Neurosurg Focus; 2001 Mar; 10(3):E6. PubMed ID: 16734409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas.
    Eisenberg MB; Woloschak M; Sen C; Wolfe D
    Surg Neurol; 1997 Feb; 47(2):156-60; discussion 160-1. PubMed ID: 9040820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fascin expression in skull base chordoma: correlation with tumor recurrence and dura erosion.
    Gao Z; Zhang Q; Kong F; Chen G; Li M; Guo H; Liang J; Bao Y; Ling F
    Med Oncol; 2012 Dec; 29(4):2438-44. PubMed ID: 22351250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First cytogenetic study of a recurrent familial chordoma of the clivus.
    Dalprà L; Malgara R; Miozzo M; Riva P; Volonte M; Larizza L; Fuhrman Conti AM
    Int J Cancer; 1999 Mar; 81(1):24-30. PubMed ID: 10077147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.
    Huang SC; Ng KF; Chang IY; Chang CJ; Chao YC; Chang SC; Chen MC; Yeh TS; Chen TC
    PLoS One; 2021; 16(1):e0245356. PubMed ID: 33481850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SWI/SNF chromatin remodeling complex alterations in meningioma.
    Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.